Search for

Professor Adam Cohen completed his term as Editor-in-Chief of the British Journal of Clinical Pharmacology (BJCP) in December 2019. In this Q&A, he looks back at his time at the journal and has a few thoughts about the future. Thank you for agreeing to talk to us about yo...

Down syndrome (DS) is the most common genomic disorder of congenital cardiac defects and intellectual disability. The most common form of DS, also known as trisomy 21, is caused by non-disjunction during meiosis of either the sperm or egg, resulting in an embryo with three co...

The story of Pharmacology Matters  Since its launch in 2008, Pharmacology Matters has provided a platform for pharmacologists in the UK and worldwide to share their research, explore key topics in the field, and highlight their experiences running events, developing their ca...

Inflammation, a natural immune response to harmful stimuli, is associated with various diseases such as cardiovascular disease, cerebrovascular conditions, diabetes, obesity, autoimmune disorders, and certain cancers when this initially beneficial response is not properly reg...

Semaglutide, more widely known under its brand name Ozempic, received authorisation for use in the EU in March 2018 . Despite the original indication to improve glycaemic control in adults with type II diabetes (T2D), evidence began to emerge that Ozempic aided with wei...

Marco Bonfanti, University of Strathclyde, is the first runner up from our annual writing competition for early career pharmacologists. Marco’s submission ‘psyched for psychedelics’ was selected by judges for its topical theme, connecting science and society. For each writ...

There are approximately 60,000 miles (100,000 km) of blood vessels in our body. The larger vessels branch off into ever smaller segments until they reach the micro scale, where curious behaviours emerge. Micro-sized blood vessels often directly interact with organ-specific ti...

Since its launch in May 2020, the Community has grown and brought together members from around the world. With nearly 1000 members active across the Community, and 27 different Networks, there are lots of ways to connect with pharmacology from wherever you are in the wor...

Each year the British Journal of Pharmacology (BJP) and the British Journal of Clinical Pharmacology (BJCP) award prizes for the best papers published by early career researchers over the previous year. Corresponding authors can nominate their eligible co-authors upon...

The Society is pleased to see recognition of two our members in the 2018 New Year's Honours list . Professor Philip Routledge, Professor Emeritus of Clinical Pharmacology at Cardiff University, has been awarded a CBE for services to medicine. Phil is an Honorary Fellow and...